Ke Xiao
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Ophthalmology top 1%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
Papers in
-
- Cancer-related molecular mechanisms research 14
- MicroRNA in disease regulation 10
-
- Retinal Diseases and Treatments 12
- Co-authors
- Thomas Thum (32 shared papers)Christian Bär (10 shared papers)Yuanjun Qin (1 shared paper)Xian Zhang (1 shared paper)Chaohua Deng (1 shared paper)Bo Chen (1 shared paper)Huimin Yu (1 shared paper)Hong Zhang (1 shared paper)
- Journals
- Scientific Reports (8 papers)Basic Research in Cardiology (4 papers)Archives of Medical Science (4 papers)Journal of Molecular and Cellular Cardiology (4 papers)European Heart Journal (3 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Ke Xiao
111 papers receiving 3.4k citations
Ke Xiao's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 1.0k
- Ophthalmology 427
- Molecular Biology 1.5k
- Cardiology and Cardiovascular Medicine 409
- Biochemistry 72
Countries citing papers authored by Ke Xiao
This map shows the geographic impact of Ke Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Xiao more than expected).
Fields of papers citing papers by Ke Xiao
This network shows the impact of papers produced by Ke Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Xiao. The network helps show where Ke Xiao may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial Hit paper breakdown → | 2022 | 365 |
| 2 | 2016 | 315 | |
| 3 | Ocular manifestations and clinical characteristics of 535 cases of COVID‐19 in Wuhan, China: a cross‐sectional study Hit paper breakdown → | 2020 | 230 |
| 4 | 2020 | 176 | |
| 5 | 2014 | 160 | |
| 6 | 2021 | 124 | |
| 7 | 2020 | 110 | |
| 8 | 2015 | 100 | |
| 9 | 2020 | 99 | |
| 10 | 2020 | 96 | |
| 11 | 2020 | 96 | |
| 12 | 2019 | 92 | |
| 13 | 2022 | 89 | |
| 14 | 2020 | 68 | |
| 15 | 2019 | 60 | |
| 16 | 2016 | 51 | |
| 17 | 2016 | 44 | |
| 18 | 2022 | 43 | |
| 19 | 2020 | 42 | |
| 20 | 2021 | 41 |
About Ke Xiao
Ke Xiao is a scholar working on Cancer Research, Ophthalmology, Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology, having authored 118 papers that have together received 3.5k indexed citations. Recurring topics across this work include Circular RNAs in diseases (15 papers), Cancer-related molecular mechanisms research (14 papers), Retinal Diseases and Treatments (12 papers), MicroRNA in disease regulation (10 papers), RNA modifications and cancer (4 papers), Extracellular vesicles in disease (4 papers), Gut microbiota and health (4 papers) and Cardiomyopathy and Myosin Studies (4 papers). The work is most often cited by research in Cancer Research (1.0k citations), Ophthalmology (427 citations), Molecular Biology (1.5k citations), Cardiology and Cardiovascular Medicine (409 citations) and Biochemistry (72 citations). Ke Xiao has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Thomas Thum, Christian Bär, Yuanjun Qin, Xian Zhang, Chaohua Deng, Bo Chen, Huimin Yu, Hong Zhang, Xuhui Chen and Liwen Chen. Their work appears in journals such as Scientific Reports, Basic Research in Cardiology, Archives of Medical Science, Journal of Molecular and Cellular Cardiology and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.